Improved prognosis of solid-type poorly differentiated colorectal adenocarcinoma: A clinicopathological and immunohistochemical study

Histopathology

Volumn 31, Issue 2, 1997, Pages 123-133

  Sugao, Y ^a   Yao, T ^a   Kubo, C ^b   Tsuneyoshi, M ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Adenocarcinoma; bcl 2; Chromogranin; Colorectum; Immunohistochemistry; Poorly differentiated; Prognosis; Solid type

Indexed keywords

CHROMOGRANIN; CYTOKERATIN; GENE PRODUCT; KI 67 ANTIGEN; MYC PROTEIN; NEURON SPECIFIC ENOLASE; PROTEIN; PROTEIN P53; PROTEIN S 100; VIMENTIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0030741318     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1997.2320843.x     Document Type: Article

References (28)

1. Jass JR, Sobin LH. WHO Histological Typing of Intestinal Tumours. Berlin: Springer-Verlag, 1989.
2. Morson BC, Dawson IMP. Gastrointestinal Pathology Oxford, London: Blackwell Scientific Publications, 1990.
3. Lockhart-Mummery HE, Ritchie JK, Hawley PR. The result of surgical treatment for carcinoma of the colorectum at St. Mark's Hospital from 1948 to 1972. Br. J. Surg. 1976; 63; 673-677.
4. Clery AP, Dockerty MB, Waugh JM. Small cell carcinoma of the colon and rectum. A clinico-pathologic study. Arch. Surg. 1961; 83; 164-172.
5. Gibbs NM. Undifferentiated carcinoma of the large intestine. Histopathology 1977; 1; 77-84.
6. Mills SE, Allen MS, Cohen AR. Small cell undifferentiated carcinoma of the colon. A clinicopathologic study of five cases and their association with colonic adenomas. Am. J. Surg. Pathol. 1983; 7; 643-651.
7. Gould VE, Chejfec G. Neuroendocrine carcinoma of the colon. Ultrastructural and biochemical evidence of their secretory function. Am. J. Surg. Pathol. 1978; 2; 31-38.
8. Gaffey MJ, Mills SE, Lack EE. Neuroendocrine carcinoma of the colon and rectum. Am. J. Surg. Pathol. 1990; 14; 1010-1023.
9. Damjanov I, Amenta PS, Bosman FT. Undifferentiated carcinoma of the colon containing exocrine, neuroendocrine and squamous cells. Virchows Arch (A) 1983; 401; 57-66.
10. Petrelli M, Tetangco E, Reid JD. Carcinoma of the colon with undifferentiated, carcinoid and squamous cell features. Am. J. Clin. Pathol. 1981; 75; 581-584.
11. Shigematsu A. Poorly differentiated carcinomas of the large intestine. A clinicopathologic study. Pathol. Clin. Med. 1985; 3; 1239-1249 (in Japanese with English abstract).
12. Chetty R, Bhathal PS. Caecal adenocarcinoma with rhabdoid phenotype: an immunohistochemical and ultrastructural analysis. Virchows Arch. A Pathol. Anat. Histopathol. 1993; 422; 179-182.
13. Yang AH, Chen WYK, Chiang H. Malignant rhabdoid tumour of colon. Histopathology 1994; 24; 89-91.
14. Japanese Research Society for Gastric Cancer. The General Rules for the Gastric Cancer Study, 12th ed. Tokyo: Kinbara Publications, 1993.
15. Ueyama T, Tsuneyoshi, M. Poorly differentiated solid type adenocarcinomas in the stomach: a clinicopathologic study of 71 cases. J. Surg. Onc. 1992; 51; 81-88.
16. Cox DR. Regression model and life tables (with discussion). J. R. Stat. Soc. (B) 1972; B34; 187-220.
17. Japanese Research Society for Cancer of the Colon and Rectum. General Rules for Clinical and Pathological Studies of the Colon. Rectum and Anus, 5th ed. Tokyo: Kinbara Publication, 1994.
18. Goseki N, Takizwa T, Koike M. Differences in the mode of the extension of gastric cancer classified by histological type: new histological classificaion of gastric carcinoma. Gut 1992; 33; 606-612.
19. Lynch HT, Smyrk TC, Watson P, Lanspa SJ et al. Genetics, natural history, tumour spectrum, and pathology of hereditary non-polyposis colorectal cancer: an update review. Gastroenterology 1993; 104; 1535-1549.
20. Lanspa SJ, Lynch HT et al. Colorectal adenomas in the Lynch syndromes. Result of a colonoscopy screening program. Gastroenterology 1990; 98; 1117-1122.
21. Lauwers GY, Scott GV, Hendricks J. Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia. Cancer 1994; 73; 2900-2904.
22. Bronner MP, Culin C, Reed JC, Furth EE. The bcl-2 proto-oncogene and the gastrointestinal tumour progression model. Am. J. Pathol. 1995; 146; 20-26.
23. Saunders JW Jr. Death in embryonic systems. Science 1966; 154; 604-612.
24. Yao T, Utsunomiya T, Nagai E et al. p53 expression patterns in colorectal adenomas and early carcinomas: a special reference to depressed adenoma and non-polypoid carcinoma. Pathol. Int. 1996; 46; 44-49.
25. Yamaguchi A, Kurosaka Y, Fushida S et al. Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer 1992; 70; 2778-2784.
26. Scott N, Sagar P, Stewart J et al. p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br. J. Cancer 1991; 63; 317-319.
27. Royds JA, Sharrard RM, Wagner B, Polacarz SV. Cellular localization of c-myc product in human colorectal epithelial tumours. J. Pathol. 1992; 166; 255-233.
28. Stewart J, Evan G, Watson J, Sikora K. Detection of the c-myc oncogene product in colonic polyps and carcinomas. Br. J. Cancer 1986; 53; 1-6.